Cancer clinical trial outcomes: Any progress in tumour-size assessment?
- 10 December 2008
- journal article
- Published by Elsevier
- Vol. 45 (2) , 225-227
- https://doi.org/10.1016/j.ejca.2008.10.025
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Recommendations for the assessment of progression in randomised cancer treatment trialsEuropean Journal Of Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Evaluation of lymph nodes with RECIST 1.1European Journal Of Cancer, 2009
- Individual patient data analysis to assess modifications to the RECIST criteriaEuropean Journal Of Cancer, 2009
- Lessons learned from independent central reviewEuropean Journal Of Cancer, 2008
- Validation of novel imaging methodologies for use as cancer clinical trial end-pointsEuropean Journal Of Cancer, 2008
- Optimising the design of phase II oncology trials: The importance of randomisationEuropean Journal Of Cancer, 2008
- Recommended changes to oncology clinical trial design: Revolution or evolution?European Journal Of Cancer, 2008
- RECIST revisited: A review of validation studies on tumour assessmentEuropean Journal Of Cancer, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000